PROTID annual meeting 2023 – project update
The PROTID (Preventive Treatment of Latent Tuberculosis Infection in people with Diabetes Mellitus) project addresses a key EDCTP prevention priority area, namely TB and comorbidities. In 2022 we initiated the first randomized controlled trial globally that evaluates the efficacy and impact of preventive treatment of latent tuberculosis infection (LTBI) in people living with diabetes. On […]
Read more